- Medicine - 08:00 Novartis real- world data at AAN confirms benefit of Gilenya on four key measures of disease activity in relapsing MS
- Life Sciences - Apr 22 The eyes have it for new camera system inspired by animal vision
- Life Sciences - Apr 21 NIH Awards Team $7 Million for Autism Genetics Research
- Medicine - Apr 21 Sandoz proposed biosimilars rituximab and etanercept recommended for approval in Europe*
- Medicine - Apr 21 US Defense supports UQ breast cancer research
- Medicine - Apr 20 How gut bacteria change cancer drug activity
- Life Sciences - Apr 20 Brain’s "hand area" used by other body parts in people born with one hand
- Medicine - Apr 20 What exactly does ‘healthy’ mean when it comes to food?
- Life Sciences - Apr 20 What makes a vegetarian? It’s not what’s on the plate
- Medicine - Apr 20 Imperial wins bid to host new UK Dementia Research Institute centre
- Agronomy - Apr 20 Hemp Summit looks at New York’s next big cash crop
- Medicine - Apr 20 Protection for the gut barrier
- Medicine - Apr 20 £13m dementia research centre
- Medicine - Apr 19 Action Required: Invasive Fungus Is Killing European Salamanders
- Life Sciences - Apr 19 High- speed images capture archer fish’s rocket- like launch
- Life Sciences - Apr 19 Natural experiment, dogged investigation, yield clue to devastating neurological disease
NIH Awards Team $7 Million for Autism Genetics Research
A research team, including scientists at Carnegie Mellon University, has received a $7 million grant from the National Institutes of Mental Health (NIMH) to extend the work of the Autism Sequencing Consortium (ASC) through 2022. The work will expand the ASC’s sample to include more than 50,000 families.
Established in 2010, the ASC collects and shares samples and genetic data from individuals diagnosed with autism spectrum disorder (ASD).
Kathryn Roeder is a principal investigator on the project.
In addition to Carnegie Mellon, team partners are the Icahn School of Medicine at Mount Sinai, the Broad Institute of MIT and Harvard, the University of Pittsburgh School of Medicine and the University of California at San Francisco.
"In our latest project we analyze the entire genomes of 500 autism families. That’s a tremendous amount of data - 3 billion base pairs per genome. The challenges involved in attempting to find a signal in such a vast amount of data are enormous," said Kathryn Roeder , professor of statistics and computational biology at CMU and a principal investigator on the project.
Currently, the ASC includes more than 150 researchers who have generated gene-sequencing data from roughly 29,000 individuals, making it the largest sequencing study to date in autism.
"Increasing the sample size so substantially is an important step in making important discoveries about the disorder," said Bernie Devlin , professor of psychiatry and human genetics at Pitt’s School of Medicine, who is also a principal investigator on the grant.
"Historically, the number of risk genes found has steadily increased with the number of patients studied, so it’s important that we continue to add patients to the data set,” said Joseph D. Buxbaum , the G. Harold and Leila Y. Mathers Research Professor of Psychiatry, Neuroscience and Genetics and Genomic Sciences at Mount Sinai. "We are thrilled to receive this grant, which will enable our unique, collaborative research consortium to continue the work that is accelerating such important discovery."
Research by the ASC has included developing new statistical tools that identified 65 genes associated with risk for ASD and predicted that several hundred more are yet to be found; providing clues about the genetic makeup of the disorder ; and determining that although rare mutations can have a big impact on genetic risk for autism, most risk stems from common inherited genetic variants.
The NIMH, part of the National Institutes of Health, previously awarded the ASC $2.25 million in 2013.
Last job offers
- Chemistry - 18.4
Doktorand/in Funktionelle Materialien
- Medicine/Pharmacology - 18.4
Professeur-e ordinaire ou associé-e, médecin-chef-fe du service de médecine interne de réhabilitation...
- Life Sciences - 15.4
Wissenschaftliche/r Mitarbeiter/in 60%
- Medicine/Pharmacology - 15.4
Chargé-e de cours à 40% dans le domaine neuro-musculaire
- Medicine/Pharmacology - 21.3
Dozentin / Dozenten für Pharmakologie und Pharmatechnologie mit Fachgruppenleitung
- Environment - 21.3
Leiter/in der Forschungsgruppe Vegetationsökologie
- Medicine/Pharmacology - 21.4
Professor of Internal Medicine of Companion Animals (0.8 - 1.0 FTE)
- Life Sciences - 21.4
Postdoc within non-coding transcription